Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Funds

SVP Fund VIII, 10/2011 $440M

Offices

Headquarter
2800 San Hill Road
Suite 150
Menlo Park, CA, 94025
USA
San Diego Office
1250 Prospect St
Ocean Level - 4
La Jolla, CA, 92037
USA
Dublin, IRL
Fitzwilliam Hall
Fitzwilliam Place
Dublin, IRL

People

General Partner
General Partner
managing partner
General Partner
Partner
Partner - HealthQuest Ventures Fund
Partner
Managing General Partner
Show All People

Tags

Sofinnova Ventures

Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build successful teams, win key customers, and navigate acquisitions and IPOs.

Sofinnova Ventures invests in Life Science and Technology start-ups. Their professionals are seasoned business operators, possessing deep domain and investment expertise. They know how to help entrepreneurs build successful, global businesses.

Recent Milestones

Investments

Company Date Round Size Participants
NuCana BioMed 4/2014Series B$57M3
ZS Pharma 3/2014Series D$55M9
Versartis 2/2014Series E$55M4
First Aid Shot Therapy 2/2014Series B4
Vestagen Technical Textiles 12/2013Series A$7.3M2
Versartis 10/2013Series D$20M6
ObsEva 8/2013Series A€25.6M2
Crocus Technology 7/2013Series D€34M5
First Aid Shot Therapy 5/2013Series A1
Auris Medical 4/2013Series C$50.6M2
ConteXtream 4/2013Venture Round$217k1
Sorbent Therapeutics 4/2013Venture Round$2.53M2
Guavus 1/2013Series D$30M5
Marinus Pharmaceuticals 1/2013Series C$21M4
Labrys Biologics 1/2013Series A$31M4
Labrys Biologics 12/2012Partial Close$14.6M3
Mirna Therapeutics 10/2012Series C$34.5M5
Aclaris Therapeutics 10/2012Series A$21M3
Cebix 10/2012Series C$30.9M3
NextWave Pharmaceuticals 10/2012Venture Round$1.82M1
CrestaTech 10/2012Venture Round$1.39M1
Catalyst Biosciences 9/2012Partial Close$13.4M5
Sorbent Therapeutics 8/2012Partial Close$18.1M3
Guavas 7/2012Series C$15M3
Histogenics 7/2012Series C$49M3
Guavus 7/2012Series C$15M3
CrestaTech 4/2012Venture Round$13M2
ENOVIX 3/2012Series C$15M2
Guavus 10/2011Series B$25M3
SARcode Bioscience 7/2011Series B$44M4
SpineVision 7/2011Venture Round$5M4
Sorbent Therapeutics 6/2011Series B$36M5
Avantium Technologies 6/2011Venture Round$43.9M7
Aerie Pharmaceuticals 3/2011Series B$41.4M5
NextWave Pharmaceuticals 1/2011Series C$45M7
Sorbent Therapeutics 9/2010Series B$21.8M4
Cebix 9/2010Venture Round$16M3
Cerenis Therapeutics 7/2010Series C€40M7
McPhy 7/2010Venture Round€13.7M3
Vicept Therapeutics 6/2010Series A$16M3
KXEN 6/2010Series D$8M5
Inside Secure. 5/2010Series D€11.2M3
MXP4 4/2010Venture Round$4M3
OpenERP 3/2010Venture Round€3M1
Laszlo Systems 1/2010Venture Round$3M4
Crescendo Biologics 1/2010Series A$7.3M3
UPEK 10/2009Venture Round$6.2M4
Alvine Pharmaceuticals 9/2009Series A$21.5M6
Intellikine 7/2009Series B$51M6
Stentys 7/2009Series B$22.2M3
Hyperion Therapeutics 6/2009Series C$60M3
CoAxia 6/2009Series D$21.5M6
Streamezzo 5/2009Series D$5.45M6
Marinus Pharmaceuticals 5/2009Series B$20M4
KaloBios Pharmaceuticals 12/2008Series D$12M8
Catalyst Biosciences 12/2008Series C$40M7
Crocus Technology 10/2008Series B€11.5M6
InteKrin 8/2008Series C$18.5M7
Streamezzo 12/2007Series C$22M7
Catalyst Mobile 10/2007Series B$10M2
VoluBill 9/2007Series D$14.8M6
Hyperion Therapeutics 9/2007Series B$40M4
Intellikine 6/2007Series B$30M1
ConteXtream 6/2007Series A$9.6M4
DiObex 4/2007Series B$24M6
HeadSprout 3/2007Series D$8M3
Phenomix 3/2007Series C$55M10
Movetis 1/2007Series A€49M7
Cortina Systems 9/2006Series D$132M7
Alvine Pharmaceuticals 9/2006Series A$8M2
Crocus Technology 6/2006Series A€13.5M5
Streamezzo 4/2006Series B$18.1M7
Network Physics 4/2006Venture Round$8.63M4
Catalyst Biosciences 2/2006Series B$30M6
Blyk 1/2006Series A€30M1
Inside Secure. 11/2005Venture Round$10.9M5
DiObex 9/2005Venture Round$7.08M3
VoluBill 1/2005Series C$14.4M5

Videos

Sources

  1. Sofinnova Ventures Closes Eight Fund at $440M (finsmes.com) [edit]
  2. NuCana Completes $57M Series B Financing (finsmes.com) [edit]
  3. ZS Pharma Completes $55 Million Financing to Advance Its Novel Investigational Treatment for Hyperkalemia (zspharma.com) [edit]
  4. Versartis Completes $55M Series E Financing (finsmes.com) [edit]
  5. First Aid Shot Therapy Completes Series B Financing Round (finsmes.com) [edit]
  6. Vestagen Technical Textiles raises $7.3 mln funding round extension (pehub.com) [edit]
  7. Versartis Completes $20M Series D Financing (finsmes.com) [edit]
  8. ObsEva SA announces CHF 32 Million Series A funding from leading Venture Capital firms and a license agreement with Merck Serono (marketwatch.com) [edit]
  9. Crocus Technology raises €34m in Series D funding (finsmes.com) [edit]
  10. First Aid Shot Therapy Raises Series A for Medicine in a Can (pevc.dowjones.com) [edit]
  11. Swiss biotech raises $50.6M to further hearing-loss drugs (fiercebiotech.com) [edit]
  12. VC Funding: Q2 2013 source [edit]
  13. VC Funding: Q2 2013 source [edit]
  14. Telecommunications Data Analytics Company Guavus Raises $30M From IGC, Intel Capital And Others (techcrunch.com) [edit]
  15. Marinus Pharmaceuticals Raises $21M Funding in Series C Financing (finsmes.com) [edit]
  16. Labrys Biologics Completes $31M Series A Financing (finsmes.com) [edit]
  17. SEC (sec.gov) [edit]
  18. Mirna Therapeutics Completes $34.5M Series C Financing (finsmes.com) [edit]
  19. Aclaris Therapeutics Secures $21M in Series A Financing (finsmes.com) [edit]
  20. Cebix Incorporated Inks $30.9m Series C and Appoints President and CEO (pehub.com) [edit]
  21. VC funding: Q4 2012 [edit]
  22. VC funding: Q4 2012 [edit]
  23. SEC (sec.gov) [edit]
  24. SEC (sec.gov) [edit]
  25. Big-Data Software Developer Guavas Captures $15M Series C (pevc.dowjones.com) [edit]
  26. Cartilage regeneration firm Histogenics raises $49M (masshightech.com) [edit]
  27. Guavus Lands $14,999,998 Series C Financing (xconomy.com) [edit]
  28. CrestaTech Raises $13M in Funding (finsmes.com) [edit]
  29. Enovix raises $15M (bizjournals.com) [edit]
  30. Guavus Receives Equity Investment from Intel Capital (finsmes.com) [edit]
  31. SARcode Bioscience Closes $44M Series B Financing (finsmes.com) [edit]
  32. SpineVision Raises $5M in Funding (finsmes.com) [edit]
  33. Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million (money.msn.com) [edit]
  34. Shell Spinoff Avantium Raises $43.9 Million To Develop Green Plastics, Chemicals And Fuel (techcrunch.com) [edit]
  35. SEC (sec.gov) [edit]
  36. NextWave Pharmaceuticals Raises $45m in a Series C Financing (finsmes.com) [edit]
  37. Sorbent Raises $21.8M Series B, Names New CEO (fis.dowjones.com) [edit]
  38. Cebix Raises $16M From Investors (xconomy.com) [edit]
  39. Cerenis Therapeutics raises EUR 40 million in series C financing (cerenis.com) [edit]
  40. Sofinnova Partners, Gimv and Amundi Private Equity Funds invest in McPhy Energy - €13.7m second round funding (gimv.com) [edit]
  41. Vicept Therapeutics Secures $10 Million to Complete Series A Funding (vicepttx.com) [edit]
  42. KXEN Secures $8 Million in Series D Funding (businesswire.com) [edit]
  43. INSIDE Contactless secures €11m, acquires SMS company (altassets.net) [edit]
  44. MXP4 raises a further $4m for its remixable music widgets (techcrunch.com) [edit]
  45. OpenERP raises 3 million euros (v6.openerp.com) [edit]
  46. Laszlo Systems raises $3M to integrate internet applications (venturebeat.com) [edit]
  47. Crescendo Biologics, Ltd.: Series A $7.3M (onbiovc.com) [edit]
  48. Upek raises $6.2M for fingerprinting software (venturebeat.com) [edit]
  49. Alvine gobbles $21.5M to treat gastrointestinal disease (venturebeat.com) [edit]
  50. Intellikine, Inc.: Series B $51M (onbiovc.com) [edit]
  51. Stentys, SAS: Series B $4.2M (onbiovc.com) [edit]
  52. Hyperion lands $60M VC round (fiercebiotech.com) [edit]
  53. CoAxia, Inc.: Series D $21.5M (onbiovc.com) [edit]
  54. Streamezzo Raises EUR4M in Investment Round and Welcomes Innovacom as New Investor (journalist-association.eu) [edit]
  55. Marinus Pharmaceuticals, Inc.: Series B $20M (onbiovc.com) [edit]
  56. KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million (kalobios.com) [edit]
  57. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
  58. Crocus Technology Receives 11.5M Euros in Second Round Funding (edageek.com) [edit]
  59. InteKrin raises $18.5M for continued work on diabetes drug (venturebeat.com) [edit]
  60. Streamezzo Secures Over US$22 Million In Round C Financing From New And Existing Investors Bringing Total Investment To US$48 Million (webitpr.com) [edit]
  61. EDGAR [edit]
  62. Volubill raise 10.5 Million Euros to fund aggressive growth strategy (volubill.com) [edit]
  63. Hyperion Therapeutics raises $40M against GI and kidney disease (venturebeat.com) [edit]
  64. EDGAR [edit]
  65. EDGAR [edit]
  66. DiObex, a metabolic disease treatment co., raises $24M (venturebeat.com) [edit]
  67. Headsprout Closes $8 Million Series D Round of Financing (haoodnla.com) [edit]
  68. PHENOMIX COMPLETES $55 MILLION SERIES C FINANCING (phenomixcorp.com) [edit]
  69. MOVETIS NV Closes 49 Million EUR Series A Financing Round (bip.lu) [edit]
  70. Cortina Systems raises $132M funding (sanjose.bizjournals.com) [edit]
  71. Alvine Pharma raises nearly $8M from Prospect, Sofinnova (venturebeat.com) [edit]
  72. Crocus Technology lève 13,5 millions d’euros (crocus-technology.com) [edit]
  73. EDGAR [edit]
  74. EDGAR [edit]
  75. CATALYST BIOSCIENCES RAISES $30 MILLION SERIES B FINANCING TO ADVANCE THERAPEUTIC PROTEASES (catalystbiosciences.com) [edit]
  76. EDGAR [edit]
  77. EDGAR [edit]
  78. EDGAR [edit]
  79. EDGAR [edit]
Edit This Page
Last Edited 4/14/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy